3,3',4'-trihydroxyflavone has been researched along with malic acid in 1 studies
| Studies (3,3',4'-trihydroxyflavone) | Trials (3,3',4'-trihydroxyflavone) | Recent Studies (post-2010) (3,3',4'-trihydroxyflavone) | Studies (malic acid) | Trials (malic acid) | Recent Studies (post-2010) (malic acid) |
|---|---|---|---|---|---|
| 39 | 0 | 22 | 2,523 | 27 | 1,047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdeaux, A; Eychenne, N; Long, R; Morin, D; Pons, S; Woodman, OL | 1 |
1 other study(ies) available for 3,3',4'-trihydroxyflavone and malic acid
| Article | Year |
|---|---|
The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats.
Topics: Animals; Cardiotonic Agents; Flavonols; Malates; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Oxygen Consumption; Pyruvic Acid; Rats, Wistar; Reactive Oxygen Species; Rotenone; Succinic Acid | 2014 |